Effect of Treatment of Chronic Hepatitis C Patients by new Antiviral Drugs | ||||
| Minia Journal of Medical Research | ||||
| Volume 31, Issue 4, October 2020, Page 152-157 PDF (351.01 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/mjmr.2022.217559 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Ibrahim . A Motawea; Ghada M. El-Sagheir; Ragaa A. Matta; Sharehan A. Ibrahim | ||||
| Department of Internal Medicine, El-Minia Faculty of Medicine | ||||
| Abstract | ||||
| Hepatitis C virus (HCV) is one of the major causes of liver disease and a potential cause of substantial morbidity and mortality worldwide. HCV genotype 4 is responsible for more than 90% of chronic HCV infection in Egypt. Aim: estimation of the response rate and detection of the effect of treatment of CHC patients on degree of fibrosis. Patients and method: 90 patients included, 30 receving interferon containing regimen and 60 receiving interferon free. Conclusion: DAAS make a revolution in HCV treatment. | ||||
| Keywords | ||||
| Hepatitis C; liver disease; interferon | ||||
|
Statistics Article View: 45 PDF Download: 140 |
||||
